No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
www.symbiopharma.comNo one on the platform currently holds 4582.T.
No tracked institution reports a position in 4582.T as of their last filing.
No one on the platform has traded 4582.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4582.TSymBio Pharmaceuticals Limited | $56.00 | +0.00% | $3.1B | — |
| 206A.TPRISM BioLab Co.,LTD | $161.00 | -3.01% | $6.0B | — |
| 4539.TNippon Chemiphar Co., Ltd. | $1550.00 | +0.00% | $5.6B | — |
| 4564.TOncoTherapy Science, Inc. | $23.00 | +4.55% | $9.2B | — |
| 4586.TMedRx Co., Ltd | $61.00 | +1.67% | $3.6B | — |
| 4597.TSolasia Pharma K.K. | $29.00 | +0.00% | $7.9B | — |
| 4598.TDelta-Fly Pharma, Inc. | $111.00 | -3.48% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry